Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neuroblastoma 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lung Neoplasms 3Leukemia, Myelomonocytic, Juvenile 3Head and Neck Neoplasms 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Recurrence 2Neoplasms 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Medulloblastoma 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Acute 2Kidney Neoplasms 2HIV Infections 2Ganglioneuroblastoma 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Burkitt Lymphoma 2Brain Neoplasms 2Acquired Immunodeficiency Syndrome 2AIDS-Related Complex 2Waldenstrom Macroglobulinemia 1Uterine Cervical Dysplasia 1Uterine Cervical Diseases 1Tumor Virus Infections 1Thrombocytopenia 1

Interventions

Paclitaxel 2Carboplatin 2pazopanib 1Isotretinoin 1Fluorouracil 1Filgrastim 1Educational Status 1Conization 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Uterine Cervical Diseases × Isotretinoin × Clear all
NCT00001073 2021-11-04

Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 3 Completed
150 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Uterine Cervical Diseases, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡